PathogenDx: Paul Glyer, Ralph Martel, Michael Drozd, Carol Dugas
PathogenDx announced four new appointments to its executive and advisory teams: Clinical & Human Diagnostics Board Advisor Paul Glyer; VP of Research and Development Ralph Martel; Food and Agriculture Advisor Michael Drozd; and Global Director of Sales Carol Dugas.
Glyer is currently the cofounder of global strategy consulting firm IOI Partners and CEO of commercial research laboratory and technology firm AhuraTech. He also serves as an executive advisor to investment firm Water Street Healthcare. He was previously SVP of strategy and business development at Beckman Coulter.
Martel is the chief technology officer at biotechnology firm Meru Biotechnologies. He was previously VP of assay platform development at SomaLogic, science director at Affymetrix, VP of R&D at HTG Molecular Diagnostics, and R&D scientist at Roche Ventana Systems.
Drozd has previously served as CEO of AgEagle Aerial Systems and president of Eurofins’ global AgBio division. He was also president and CEO of food technology company Aseptia/Wright Foods.
Dugas was previously the Eastern region sales manager at PathogenDx and has served as the North America senior sales director of biomonitoring for life science reagent and biochemistry firm MilliporeSigma.